|
"dai chia yen"的相关文件
显示项目 26-64 / 64 (共2页)
1 2 > >>
每页显示[10|25|50]项目
| 國立交通大學 |
2019-09-02T07:46:16Z |
Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection
|
Hsu, Chia-Chang; Hsieh, Pei-Min; Chen, Yaw-Sen; Lo, Gin-Ho; Lin, Hung-Yu; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Yao-Li; Yu, Ming-Lung; Lin, Chih-Wen |
| 國立交通大學 |
2019-08-02T02:18:36Z |
Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C
|
Batsaikhan, Batbold; Lu, Ming-Ying; Yeh, Ming-Lun; Huang, Ching-, I; Huang, Chung-Feng; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Hsieh, Ping-Hsin; Chuang, Wan-Long; Lee, Jin-Ching; Yu, Ming-Lung; Dai, Chia-Yen |
| 國立交通大學 |
2019-08-02T02:18:29Z |
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Wei, Yu-Ju; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-08-02T02:15:26Z |
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals
|
Perez, Shira; Kaspi, Antony; Domovitz, Tom; Davidovich, Ateret; Lavi-Itzkovitz, Anat; Meirson, Tomer; Holmes, Jacinta Alison; Dai, Chia-Yen; Huang, Chung-Feng; Chung, Raymond T.; Nimer, Assy; El-Osta, Assam; Yaari, Gur; Stemmer, Salomon M.; Yu, Ming-Lung; Haviv, Izhak; Gal-Tanamy, Meital |
| 國立交通大學 |
2019-04-02T06:01:07Z |
Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication
|
Huang, Chung-Feng; Wang, Shu-Chi; Yeh, Ming-Lun; Huang, Ching-I; Tsai, Pei-Chien; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Angela; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T06:00:31Z |
Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Chen, Jyh-Jou; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:55Z |
Association of hyperuricemia with disease severity in chronic hepatitis C patients
|
Jang, Tyng-Yuan; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Hsieh, Meng-Hsuan; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:49Z |
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection
|
Huang, Chung-Feng; Wang, Shu-Chi; Chang, Wen-Tsan; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Chuang, Wan-Long; Huang, Jee-Fu; Dai, Chia-Yen; Chen, Yao-Li; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:44Z |
Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection
|
Lin, Chih-Wen; Chen, Yaw-Sen; Lin, Chih-Che; Lee, Po-Huang; Lo, Gin-Ho; Hsu, Chia-Chang; Hsieh, Pei-Min; Koh, Kah Wee; Chou, Tsung-Ching; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Yao-Li; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:37Z |
A real world cost effectiveness analysis of interferon-based therapy for HCV naive super-responders
|
Tsai, Pei-Chien; Liu, Ta-Wei; Huang, Chung-Feng; Yeh, Ming-Lun; Dai, Chia-Yen; Chuang, Wan-Long; Huang, Jee-Fu; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:10Z |
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:57:55Z |
Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection
|
Lin, Chih-Wen; Chen, Yaw-Sen; Lin, Chih-Che; Lee, Po-Huang; Lo, Gin-Ho; Hsu, Chia-Chang; Hsieh, Pei-Min; Koh, Kah Wee; Bair, Ming-Jong; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Yao-Li; Yu, Ming-Lung |
| 臺大學術典藏 |
2018-09-10T15:22:34Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Huang, Chung-Feng; PEI-JER CHEN; Liu, Chun-Jen; Dai, Chia-Yen; CHEN-HUA LIU; DING-SHINN CHEN; Huang, Jee-Fu; Lin, Jou-Wei; TUNG-HUNG SU; JIA-HORNG KAO; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2018-09-10T15:18:40Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維; Hsu, Feng-Ming; Liu, Chen-Hua; YIH-LEONG CHANG; Cheng, Jason Chia-Hsien; Huang, Chung-Feng; ERIC YAO-YU CHUANG; Chang, Yih-Leong; JANG-MING LEE; Liu, Chun-Jen; Dai, Chia-Yen; Lee, Jang-Ming; Huang, Jee-Fu; Koong, Albert C.; Lin, Jou-Wei; Chuang, Eric Y.; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Chang, Yih-Leong;Lee, Jang-Ming;Koong, Albert C.;Chuang, Eric Y.; Hsu, F.-M. and Cheng, J.C.-H. and Chang, Y.-L. and Lee, J.-M. and Koong, A.C. and Chuang, E.Y.; 張逸良;成佳憲;李章銘;許峰銘; 成佳憲 |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng;Yu, Ming-Lung;Kao, Jia-Horng;Tseng, Tai-Chung;Yeh, Ming-Lun;Huang, Jee-Fu;Dai, Chia-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Wang, Liang-Yen;Juo, Suh-Hang Hank;Chuang, Wan-Long;Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Yu, Ming-Lung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; Yeh, Ming-Lun; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Chuang, Wan-Long; Liu, Chen-Hua; Liu, Chen-Hua |
| 臺大學術典藏 |
2018-09-10T09:49:30Z |
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study
|
Wong, Grace Lai Hung; JIA-HORNG KAO; Huang, Jee-Fu; Wong, Vincent Wai Sun; Wong, Vincent Wai Sun; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung; Chuang, Wan-Long; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; Chan, Henry Lik Yuen; Chen, Ding-Shinn; Chen, Ding-Shinn; Tseng, Tai-Chung; Wong, Grace Lai Hung; DING-SHINN CHEN; Dai, Chia-Yen; CHUN-JEN LIU; Dai, Chia-Yen;Tseng, Tai-Chung;Wong, Grace Lai Hung;Huang, Jee-Fu;Wong, Vincent Wai Sun;Liu, Chun-Jen;Yu, Ming-Lung;Chuang, Wan-Long;Kao, Jia-Horng;Chan, Henry Lik Yuen;Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:47:26Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, H.-C. and Chen, C.-L. and Shen, Y.-C. and Peng, C.-Y. and Liu, C.-J. and Tseng, T.-C. and Su, T.-H. and Chuang, W.-L. and Yu, M.-L. and Dai, C.-Y. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Yang, Hung-Chih; HUNG-CHIH YANG; CHUN-JEN LIU; Chen, Chi-Ling; Shen, Yueh-Chi; PEI-JER CHEN; Peng, Cheng-Yuan; CHEN-HUA LIU; TUNG-HUNG SU; Liu, Chun-Jen; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
|
Dai, Chia-Yen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Chen, Shih-I;Lin, Jou-Wei;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; Liu, Chen-Hua; Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Huang, Chung-Feng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:14:10Z |
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Re, Valli De; CHEN-HUA LIU; Yu, Ming-Lung; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; RE, Valli DE |
| 臺大學術典藏 |
2018-09-10T05:02:40Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei, DJ;Hsu, HC;Lee, PH;Jeng, YM;Pu, YS;Chen, CN;Lee, YC;Chou, WC;Chang, CJ;Ni, YH;Chang, MH.; Tsuei, D.-J. and Hsu, H.-C. and Lee, P.-H. and Jeng, Y.-M. and Pu, Y.-S. and Chen, C.-N. and Lee, Y.-C. and Chou, W.-C. and Chang, C.-J. and Ni, Y.-H. and Chang, M.-H.; Liu, Chen-Hua; Tsuei, DJ; PO-HUANG LEE; Hsu, HC; Huang, Chung-Feng; MEI-HWEI CHANG; Lee, PH; Liu, Chun-Jen; CHIUNG-NIEN CHEN; YUNG-MING JENG; Dai, Chia-Yen; Jeng, YM; Yen-Hsuan Ni; Huang, Jee-Fu; Pu, YS; Chen, CN; Lin, Jou-Wei; YEONG-SHIAU PU; Lee, YC; Liang, Cheng-Chao; Chou, WC; Yang, Sheng-Shun; Lin, Chih-Lin; Chang, CJ; Su, Tung-Hung; Ni, YH; Yang, Hung-Chih; Chang, MH.; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立交通大學 |
2018-08-21T05:53:33Z |
Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 嘉南藥理大學 |
2016-04 |
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
|
Wu, Kuan-Ta; Kuo, Po-Lin; Su, Shih-Bin; Chen, Yi-Yu; Yeh, Ming-Lum; Huang, Ching-I; Yang, Jeng-Fu; Lin, Chia-I; Hsieh, Meng-Hsuan; Hsieh, Ming-Yen; Huang, Chung-Feng; Lin, Wen-Yi; Yu, Ming-Lung; Dai, Chia-Yen; Wang, Hsien-Yi |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 嘉南藥理大學 |
2014-02 |
High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
|
Yu, Ming-Lung; Dai, Chia-Yen; Huang, Chung-Feng; Lee, Jia-Jung; Yeh, Ming-Lun; Yeh, Shih-Meng; Kuo, Hsing-Tao; Huang, Jee-Fu; Chang, Jer-Ming; Chen, Hung-Chun; Juo, Suh-Hang Hank; Hwang, Shang-Jyh; Chuang, Wan-Long |
| 嘉南藥理大學 |
2014 |
Discrepancy between Serological and Virological Analysis of Viral Hepatitis in Hemodialysis Patients
|
Chang, Jer-Ming; Huang, Chung-Feng; Chen, Szu-Chia; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Jee-Fu; Kuo, Hsing-Tao; Chuang, Wan-Long; Yu, Ming-Lung; Hwang, Shang-Jyh; Chen, Hung-Chun |
| 國立臺灣大學 |
2014 |
Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2013 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng; Yu, Ming-Lung; Kao, Jia-Horng; Tseng, Tai-Chung; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Liu, Chen-Hua; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2013 |
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study
|
Dai, Chia-Yen; Tseng, Tai-Chung; Wong, Grace Lai Hung; Huang, Jee-Fu; Wong, Vincent Wai Sun; Liu, Chun-Jen; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Chan, Henry Lik Yuen; Chen, Ding-Shinn; 陳定信; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2013 |
Pegylated Interferon-alpha 2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 嘉南藥理大學 |
2012-05 |
Erratum to:"Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin"[J Hepatol 2012;56:34–40]
|
Huang, Chung-Feng; Huan, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 嘉南藥理大學 |
2012 |
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
|
Huang, Chung-Feng; Huang, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 國立臺灣大學 |
2012 |
Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2012 |
Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 高雄醫學大學 |
2009 |
Insight into alcohol consumption-related problems and its correlates among Taiwanese alcoholic hepatogastroenterological clinic patients
|
顏正芳; Yen, Cheng-Fang;Dai, Chia-Yen;Hou, Nai-Jen;Ray, C.Hsiao;Yu , Ming-Lung |
显示项目 26-64 / 64 (共2页)
1 2 > >>
每页显示[10|25|50]项目
|
